Novartis and Roche's big-selling eye drug Lucentis has its first biosimilar competitor in Europe, after the European Commission approved Samsung Bioepis' copycat drug Byooviz. Byooviz (ranibizumab ...
It cites an “anticompetitive agreement” in the market for Lucentis active ingredient, the anti-VEGF antibody ranibizumab. Specifically, the ACGM claims that the companies entered into a ...
Dubai Marina is famous for its high-rise towers, entertainment venues, nightlife options and artificial marina. Among the glitzy high-rises, Marina Tower is a residential development offering 1, 2 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback